Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 |
|---|---|---|---|
| Revenue | 676M | 693M | 84M |
| Cost of revenue | 4M | 20M | 71M |
| Gross profit | 672M | 673M | 13M |
| Research and development | 86M | 103M | 138M |
| Selling, general and administrative | 1.12B | 1.22B | 343M |
| Operating expenses | 1.21B | 1.33B | 481M |
| Operating income | −534M | −652M | −468M |
| Pre-tax income | −535M | −662M | −479M |
| Net income | −535M | −662M | −479M |
| Earnings per share | −12.70 | −16.10 | −12.30 |
| Earnings per share, diluted | −12.70 | −16.10 | −12.30 |
| Weighted average shares | 42M | 41M | 39M |
| Weighted average shares, diluted | 42M | 41M | 39M |
| Metric | 18/08/2026 | 31/03/2025 | 31/12/2024 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|---|
| Cash and equivalents | — | 112M | — | 472M | 451M | — |
| Receivables | — | 21M | — | 84M | — |
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 |
|---|---|---|---|
| Operating cash flow | −283M | −317M | −134M |
| Depreciation and amortisation | 3M | 2M | 220,000 |
| Capital expenditure | 8M | 3M | 437,000 |
| Investing cash flow | −13M | −9M | −11M |
| Financing cash flow |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| — |
| Current assets | — | 278M | — | 709M | — | — |
| Property, plant and equipment | — | 7M | — | 2M | — | — |
| Total assets | — | 314M | — | 744M | — | — |
| Current liabilities | — | 526M | — | 572M | — | — |
| Total liabilities | — | 965M | — | 860M | — | — |
| Equity | — | −651M | — | −117M | 177M | 303M |
| Shares outstanding | — | 42M | 42M | 42M | — | — |
| Shares issued | — | 42M | 42M | 42M | — | — |
| −64M |
| 346M |
| 307M |